EUVIMEDEUVIMED entdecken
Crossref

Olanzapine-induced restless legs syndrome: Two case reports

Hong-Liang Li

World Journal of Psychiatry · 19.08.2026 · 16 (8)

DOI: 10.5498/wjp.120880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Psychiatry, online erschienen am 19.08.2026. Verfasst von Hong-Liang Li. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Olanzapine, a second-generation antipsychotic acting as a serotonin-dopamine antagonist, is widely used in the treatment of schizophrenia, bipolar disorder and other psychiatric illnesses. Common adverse effects of olanzapine include somnolence, weight gain, metabolic syndrome, and extrapyramidal symptoms. However, olanzapine-induced restless legs syndrome (RLS) is a rare adverse reaction, with a reported incidence of only 0.5%-2.3% in clinical trials, which is easily overlooked in clinical practice. To date, few case reports have systematically described the clinical characteristics of olanzapine-induced RLS in schizophrenia patients with long-term disease course and multiple comorbidities. I here report two cases of olanzapine-induced RLS, summarize the diagnostic and therapeutic experience, and review relevant literature to improve clinicians’ awareness of this adverse reaction. CASE SUMMARY The clinical data of two chronic schizophrenia patients who developed RLS after olanzapine administration in December of the admission year were retrospectively collected and analyzed. Combined with a systematic review of relevant literature, the pathogenesis, differential diagnosis and management strategies of olanzapine-induced RLS were discussed. CONCLUSION Olanzapine may induce RLS by interfering with the dopaminergic system and iron metabolism. Clinicians should closely monitor sleep quality and lower extremity discomfort in schizophrenia patients treated with olanzapine, promptly identify RLS and implement individualized interventions to improve treatment adherence and quality of life.

Zitieren

APA

Li, H. (2026). Olanzapine-induced restless legs syndrome: Two case reports. World Journal of Psychiatry, 16(8). https://doi.org/10.5498/wjp.120880

Vancouver

Li H. Olanzapine-induced restless legs syndrome: Two case reports. World Journal of Psychiatry. 2026;16(8). doi:10.5498/wjp.120880

BibTeX
@article{Li2026,
  author = {Li, Hong-Liang},
  title = {Olanzapine-induced restless legs syndrome: Two case reports},
  journal = {World Journal of Psychiatry},
  year = {2026},
  volume = {16},
  number = {8},
  doi = {10.5498/wjp.120880}
}
Kostenlos starten →